ArticleJournal of thoracic disease2026
Comorbidity of chronic obstructive pulmonary disease and pulmonary tuberculosis: a bibliometric analysis (2011-2025) with narrative review.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic obstructive pulmonary disease (COPD) and pulmonary tuberculosis (PTB) are major global respiratory diseases that frequently coexist, particularly in low- and middle-income countries. This study combined bibliometric analysis with a narrative review to explore research trends, hotspots, and advancements in COPD-PTB comorbidity. Methods: We analyzed studies from the Web of Science (2011-2025) using VOSviewer and CiteSpace for bibliometric visualization, alongside a narrative review of key studies covering epidemiology, diagnosis, pulmonary function, biomarkers, mechanisms, and imaging. Results: Publications peaked in 2024, with China contributing the most papers (n=242) and the United States receiving the most citations (n=7,977). The most prolific journal was the Conclusions: This study highlights the significant comorbidity between COPD and PTB, with both conditions exacerbating each other's severity and worsening patient prognosis. Epidemiological data confirm that a history of PTB increases the risk of developing COPD, and vice versa. Advances in biomarkers and imaging techniques, such as AI-assisted CT and DECT, offer promising avenues for early diagnosis and better management. Future work should focus on multimodal diagnostic frameworks, disease-specific biomarkers, and radiomics-based imaging to improve recognition and management of COPD-PTB comorbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.